Glucose-induced electrical activity in rat pancreatic beta-cells: dependence on intracellular chloride concentration.
A rise in glucose concentration depolarizes the beta-cell membrane potential leading to electrical activity and insulin release. It is generally believed that closure of KATP channels underlies the depolarizing action of glucose, though work from several laboratories has indicated the existence of an additional anionic mechanism. It has been proposed that glucose activates a volume-regulated anion channel, generating an inward current due to Cl- efflux. This mechanism requires that intracellular [Cl-] is maintained above its electrochemical equilibrium. This hypothesis was tested in rat beta-cells by varying [Cl-] in the patch pipette solution using the Cl--permeable antibiotic amphotericin B to allow Cl- equilibration with the cell interior. Under such conditions, a depolarization and electrical activity could be evoked by 16 mM glucose with pipette solutions containing 80 or 150 mM Cl-. At 40 or 20 mM Cl-, a subthreshold depolarization was usually observed, whilst further reduction to 12 or 6 mM abolished depolarization, in some cases leading to a glucose-induced hyperpolarization. With a pipette solution containing gramicidin, which forms Cl--impermeable pores, glucose induced a depolarization and electrical activity irrespective of [Cl-] in the pipette solution. Under the latter conditions, glucose-induced electrical activity was prevented by bumetanide, an inhibitor of the Na+-K+-2Cl- co-transporter. This inhibition could be overcome by the use of amphotericin B with a high [Cl-] pipette solution. These findings suggest that the maintenance of high intracellular [Cl-] in the beta-cell is an important determinant in glucose-induced depolarization, and support the hypothesis that beta-cell stimulation by glucose involves activation of the volume-regulated anion channel and generation of an inward Cl- current.
Best
L
L
Department of Medicine, University of Manchester, Multipurpose Building, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL, UK. len.best@cmmc.nhs.uk
D000666:Amphotericin B / Q000494:pharmacology; D000818:Animals; D002034:Bumetanide / Q000494:pharmacology; D048429:Cell Size / Q000187:drug effects; D002712:Chlorides / Q000737:chemistry / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D006096:Gramicidin / Q000494:pharmacology; D066298:In Vitro Techniques; D007424:Intracellular Fluid / Q000737:chemistry; D015640:Ion Channel Gating / Q000187:drug effects / Q000502:physiology; D007515:Islets of Langerhans / Q000187:drug effects* / Q000502:physiology; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000494:pharmacology
D002712:Chlorides; D049994:Sodium Potassium Chloride Symporter Inhibitors; D002034:Bumetanide; D006096:Gramicidin; D000666:Amphotericin B; D005947:Glucose